News from curevac ag A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 23, 2017, 08:02 ET Publication in npj Vaccines Demonstrates CureVac's RNActive® Vaccine is Superior to Licensed Vaccines

CureVac AG, a fully-integrated biotechnology company pioneering mRNA-based drugs, today announced the publication of a study in the peer-reviewed...


Aug 15, 2017, 08:02 ET Publication in EMBO Molecular Medicine Demonstrates CureVac's Proprietary mRNA Technology Enables Antibody Mediated Therapies Against Infectious Agents, Toxins and Tumors

CureVac AG, a fully-integrated biotechnology company pioneering mRNA-based drugs, today announced the publication of a study in the peer-reviewed...


Jul 26, 2017, 07:03 ET CureVac Announces Publication in The Lancet of First-Ever Human Proof-of-Concept Study Investigating the Safety and Immunogenicity of a Prophylactic mRNA Vaccine

CureVac AG, a fully-integrated biotechnology company pioneering mRNA-based drugs, today announced that the results of CureVac's phase I clinical...


Jul 20, 2017, 08:00 ET CureVac to Receive Patent Claiming the Combination of mRNA Vaccines with Anti-PD-1 Antibodies

CureVac AG, a fully-integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced it has been granted a Notice of...


Jun 26, 2017, 10:17 ET CureVac Expands GMP Production Capacities for RNA Products

CureVac AG, a fully-integrated biopharmaceutical company pioneering the field of mRNA-based drugs, announced during a public open door event at its...


Jun 13, 2017, 08:15 ET CureVac Extends Global Intellectual Property Estate for Prophylactic mRNA Vaccines

CureVac AG, a fully-integrated biotechnology company pioneering mRNA based drugs, today announced it has been granted important patents claiming the...


May 18, 2017, 16:42 ET CureVac to Present at Upcoming International Investor Conferences

CureVac AG, the most clinically advanced mRNA company, today announced that the company will present at two upcoming international investor...


May 02, 2017, 08:30 ET CureVac Appoints Daniel Menichella as CEO of CureVac Inc., the Company's US Subsidiary

CureVac AG, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based therapies, today announced the appointment of Daniel...


Dec 28, 2016, 10:00 ET CureVac to Present at the J.P. Morgan 35th Annual Healthcare Conference 2017

CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, announced today that Ingmar Hoerr, Ph.D.,...


Nov 08, 2016, 11:45 ET CureVac Secures an Additional $29.5 Million From Two New Investors

CureVac AG today announced that the company secured a total of $29.5 million in a financing led by new investors Baden-Württembergische...


Nov 08, 2016, 08:00 ET CureVac Receives Broad Patent for RNAntibody® Technology

CureVac AG today announced that it has been granted a patent (patent No. EP2101823, publication of grant on Nov 23, 2016) by the European Patent...


Oct 11, 2016, 08:00 ET CureVac Appoints Pierre Kemula as Chief Financial Officer

CureVac AG, the most clinically advanced mRNA company, today announced the appointment of Pierre Kemula as Chief Financial Officer (CFO). Mr. Kemula...


Jul 14, 2016, 10:17 ET Study in Peer-Reviewed Journal Vaccine Demonstrates Decoding Mode of Action of mRNA Vaccines

CureVac AG, the most clinically advanced mRNA company, today announced that a study of its RNActive® technology was published in the renowned,...


Feb 18, 2016, 10:17 ET CureVac announces "MERAN" has been approved by the World Health Organization as suffix for mRNA drug substances

CureVac AG, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, today announced that the World Health...


Oct 15, 2015, 10:17 ET The 3rd International mRNA Health Conference to Celebrate Historic 2015 as "mRNA Grabs the Spotlight"

Amid a torrent of advancements and interest in mRNA science and industry, the 3rd International mRNA Health Conference is set to commence on November ...